This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Dose of Bright Near-Term Outlook From Medical-Hospital Industry
by Sapna Bagaria
Investment in technology, an aging population and continuous consolidation offers attractive growth opportunity for the industry.
Why Hold Strategy is Apt for Universal Health (UHS) Now
by Zacks Equity Research
Universal Health (UHS) is well-positioned to reap benefits for investors on the back of its rising top line, capital strength and solid performances at both Acute Care and Behavioral Health segments.
HCA Healthcare Acquires Valify to Rein in Medical Costs
by Zacks Equity Research
HCA Healthcare (HCA) completes the buyout of technology company Valify to identify opportunities for reducing expenses.
Why Should You Hold HCA Healthcare in Your Portfolio Now?
by Zacks Equity Research
Riding high on its growing revenues and a firm capital position, HCA Healthcare (HCA) holds potential to reap benefits for investors.
HCA Healthcare Acquires Galen, Expands Nursing Schools
by Sapna Bagaria
The acquisition of a majority ownership of Galen College of Nursing provides HCA Healthcare (HCA) with consistent availability of nurses.
MEDNAX Expands Further in Florida With Radiology Affiliation
by Zacks Equity Research
MEDNAX (MD) forms an association with Boca Radiology Group to strengthen its radiology business in Florida.
Community Health Divests Hospitals to Reduce Debt Level
by Zacks Equity Research
Community Health (CYH) continues to divest hospitals to focus on core operations and reduce debt burden.
Community Health Lags Industry YTD: Will it Reverse in 2020?
by Zacks Equity Research
Backed by lower expenses, debt repayment and business streamlining, Community Health (CYH) holds enough potential to grow in 2020.
Why Should You Hold Universal Health in Your Portfolio?
by Zacks Equity Research
Banking on its growing top line and strong segments, Universal Health (UHS) holds potential to reap benefits for investors.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.
Universal Health's (UHS) Earnings Lag in Q3, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are hurt by high operating expenses.
Universal Health Services (UHS) Q3 Earnings Lag Estimates
by Zacks Equity Research
Universal Health Services (UHS) delivered earnings and revenue surprises of -11.95% and 2.42%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
What to Expect for Universal Health's (UHS) Q3 Earnings
by Zacks Equity Research
Universal Health (UHS) is likely to have benefited from strong segmental performances at Acute Care and Behavioral Health in Q3, partly offset by high costs.
Universal Health Services (UHS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Universal Health Services (UHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health (UHS) Up 27.6% YTD: Will the Rally Continue?
by Zacks Equity Research
Universal Health (UHS) is poised to grow over the long term on the back of strong contribution from its segments and accretive acquisitions.
MEDNAX Teams Up With CENTA to Expand Services in Florida
by Zacks Equity Research
MEDNAX (MD) inks a partnership deal with CENTA to strengthen its profile of varied healthcare solutions in Florida.
Hospital Industry Outlook: Rising Baby Boomers to Drive Growth
by Sapna Bagaria
The Zacks Medical-Hospital industry is set to gain from demographic changes and growing consolidation amid high labor cost.
Top Stock Reports for Apple, Exxon Mobil & AT&T
by Mark Vickery
. Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), Exxon Mobil (XOM) and AT&T (T).
5 Factors That Make Acadia Healthcare Stock Look Unattractive
by Zacks Equity Research
Rising expenses, underperforming U.K business and low guidance are a drag on Acadia Healthcare's (ACHC) stock.
Ensign Group Acquires Nursing Facility to Expand in Idaho
by Zacks Equity Research
Ensign Group (ENSG) purchases the real estate and the operations of Temple View Transitional Care Center in Idaho to boost its presence in the state.
Humana (HUM) Ties Up to Boost Medicare Advantage Network
by Zacks Equity Research
Humana (HUM) collaborates with Iora Health to strengthen its Medicare Advantage network across Texas, Georgia and Arizona.
3 Reasons Growth Investors Will Love Universal Health Services (UHS)
by Zacks Equity Research
Universal Health Services (UHS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why You Should Avoid Acadia Healthcare Stock Now
by Zacks Equity Research
Lack of clarity on the sale of its underperforming U.K. business continues to hurt Acadia Healthcare (ACHC).
Mednax Collaborates With Northern Indiana Neonatal Associates
by Zacks Equity Research
Mednax (MD) joins forces with Northern Indiana Neonatal Associates in Fort Wayne to enhance its neonatal services.
Humana Ties Up to Enhance Facilities for Members in Michigan
by Zacks Equity Research
Humana (HUM) teams up with McLaren Physician Partners to provide in-network access to its members in Michigan.